4//SEC Filing
STRAUSS ROBERT C 4
Accession 0000815838-04-000003
CIK 0000815838other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 11:42 AM ET
Size
11.6 KB
Accession
0000815838-04-000003
Insider Transaction Report
Form 4
STRAUSS ROBERT C
DirectorPresident, CEO & Chairman
Transactions
- Exercise/Conversion
Common Stock ($.0001 Par Value)
2004-01-02$6.18/sh+66,374$410,191→ 127,258 total - Sale
Common Stock ($.0001 Par Value)
2004-01-02$15.19/sh−2,004$30,441→ 115,884 total - Exercise/Conversion
Common Stock ($.0001 Par Value)
2004-01-05$6.18/sh+13,500$83,430→ 74,384 total - Sale
Common Stock ($.0001 Par Value)
2004-01-02$15.05/sh−50,000$752,500→ 60,884 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-01-05−13,500→ 275,125 totalExercise: $6.18Exp: 2004-12-11→ Common Stock (13,500 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2004-01-02−66,374→ 288,625 totalExercise: $6.18Exp: 2004-12-11→ Common Stock (66,374 underlying) - Sale
Common Stock ($.0001 Par Value)
2004-01-02$15.15/sh−5,000$75,750→ 110,884 total - Sale
Common Stock ($.0001 Par Value)
2004-01-02$15.28/sh−9,370$143,145→ 117,888 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2003.
- [F2]10% exercisable after 12/12/1998; 20% exercisable after 12/12/1999; 20% exercisable after 12/12/2000; 25% exercisable after 12/12/2001; 25% exercisable after 12/12/2002.
Documents
Issuer
NOVEN PHARMACEUTICALS INC
CIK 0000815838
Entity typeother
Related Parties
1- filerCIK 0001224100
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 11:42 AM ET
- Size
- 11.6 KB